Ma JL - Search Results

1

Sun QK, Wang W, Zhou HC, Lv Y, Yu JH, Ma JL, Jia WD, Xu GL. Sun QK, et al. Among authors: ma jl. Oncol Lett. 2014 Jun;7(6):2089-2092. doi: 10.3892/ol.2014.2019. Epub 2014 Apr 1. Oncol Lett. 2014. PMID: 24932294 Free PMC article.

2

Antitumoral activity of rapamycin mediated through inhibition of HIF-1alpha and VEGF in hepatocellular carcinoma.

Wang W, Jia WD, Xu GL, Wang ZH, Li JS, Ma JL, Ge YS, Xie SX, Yu JH. Wang W, et al. Among authors: ma jl. Dig Dis Sci. 2009 Oct;54(10):2128-36. doi: 10.1007/s10620-008-0605-3. Epub 2008 Dec 4. Dig Dis Sci. 2009. PMID: 19052864

3

[Prevention of hepatic tumor growth and metastasis in rats with rapamycin].

Wang W, Xu GL, Jia WD, Wang ZH, Li JS, Ma JL, Ge YS. Wang W, et al. Among authors: ma jl. Zhonghua Gan Zang Bing Za Zhi. 2009 Mar;17(3):193-7. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19335982 Chinese.

4

A somatostatin analogue, octreotide, inhibits the occurrence of second primary tumors and lung metastasis after resection of hepatocellular carcinoma in mice.

Jia WD, Xu GL, Wang W, Wang ZH, Li JS, Ma JL, Ren WH, Ge YS, Yu JH, Liu WB. Jia WD, et al. Among authors: ma jl. Tohoku J Exp Med. 2009 Jun;218(2):155-60. doi: 10.1620/tjem.218.155. Tohoku J Exp Med. 2009. PMID: 19478472 Free article.

5

Ligation of TLR2 by versican: a link between inflammation and metastasis.

Wang W, Xu GL, Jia WD, Ma JL, Li JS, Ge YS, Ren WH, Yu JH, Liu WB. Wang W, et al. Among authors: ma jl. Arch Med Res. 2009 May;40(4):321-3. doi: 10.1016/j.arcmed.2009.04.005. Epub 2009 May 21. Arch Med Res. 2009. PMID: 19608024

6

Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma.

Liu WB, Xu GL, Jia WD, Li JS, Ma JL, Chen K, Wang ZH, Ge YS, Ren WH, Yu JH, Wang W, Wang XJ. Liu WB, et al. Among authors: ma jl. Med Oncol. 2011 Dec;28 Suppl 1:S228-38. doi: 10.1007/s12032-010-9706-x. Epub 2010 Oct 19. Med Oncol. 2011. PMID: 20957524

7

Extracellular matrix protein 1, a novel prognostic factor, is associated with metastatic potential of hepatocellular carcinoma.

Chen H, Jia WD, Li JS, Wang W, Xu GL, Ma JL, Ren WH, Ge YS, Yu JH, Liu WB, Zhang CH, Wang YC. Chen H, et al. Among authors: ma jl. Med Oncol. 2011 Dec;28 Suppl 1:S318-25. doi: 10.1007/s12032-010-9763-1. Epub 2010 Dec 3. Med Oncol. 2011. PMID: 21128013

8

[Effects of celecoxib combined with fluvastatin on tumor growth and cell apoptosis in a xenograft model of hepatocellular carcinoma].

Gao J, Li JS, Xu GL, Jia WD, Ma JL, Yu JH, Ge YS. Gao J, et al. Among authors: ma jl. Zhonghua Gan Zang Bing Za Zhi. 2010 Dec;18(12):900-4. doi: 10.3760/cma.j.issn.1007-3418.2010.12.005. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 21205474 Chinese.

9

[Expression of estrogen receptor α in hepatitis B-related hepatocellular carcinoma and its clinical significance].

Han SJ, Xu GL, Jia WD, Wang YC, Li JS, Ma JL, Ren WH, Ge YS, Liu WB, Zhang CH, Wang W. Han SJ, et al. Among authors: ma jl. Zhonghua Wai Ke Za Zhi. 2010 Dec 15;48(24):1875-80. Zhonghua Wai Ke Za Zhi. 2010. PMID: 21211272 Chinese.

10

Activation of STAT3 signal pathway correlates with twist and E-cadherin expression in hepatocellular carcinoma and their clinical significance.

Zhang CH, Xu GL, Jia WD, Li JS, Ma JL, Ren WH, Ge YS, Yu JH, Liu WB, Wang W. Zhang CH, et al. Among authors: ma jl. J Surg Res. 2012 May 1;174(1):120-9. doi: 10.1016/j.jss.2010.10.030. Epub 2010 Nov 23. J Surg Res. 2012. PMID: 21316706

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

489 results

Search Page